Table: Cosmos Pharmaceutical - 9-MTH group results

Cosmos Pharmaceutical

14/04/2025 07:30

Apr 14 (Reuters)- 
             Cosmos Pharmaceutical Corp. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Feb 28, 2025        Feb 29, 2024     May 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            752.27              715.31          1.04 trln  
                 (+5.2 pct)          (+18.0 pct)      (+7.5 pct)  
  Operating         31.63               23.74            31.60    
                 (+33.2 pct)         (+7.1 pct)       (+0.3 pct)  
  Recurring         33.77               25.91            34.40    
                 (+30.3 pct)         (+6.2 pct)       (+0.3 pct)  
  Net               22.34               17.36            24.50    
                 (+28.7 pct)         (+6.6 pct)       (+0.2 pct)  
  EPS            281.91 yen          219.07 yen       309.12 yen  
  Ann Div                            120.00 yen        65.00 yen  
  -Q2 div         32.50 yen           60.00 yen                   
  -Q4 div                             60.00 yen        32.50 yen  
  
  NOTE - Cosmos Pharmaceutical Corp.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T